Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study
Philip A. Philip, Jill Lacy, Fabienne Portales, Alberto F. Sobrero, Roberto Pazo-Cid, José Luis Manzano Mozo, Edward Kim, Scot Dowden, Ahmed Zakari, Christophe Borg, Eric Terrebonne, Fernando Rivera, Javier Sastre, Venu Bathini, Daniel López‐Trabada, Jamil Asselah, Muhammad Wasif Saif, Jack Shiansong Li, Teng Jin Ong, Thomas Nydam, Pascal Hammel
Topics & Concepts
MedicineGemcitabineClinical endpointPancreatic cancerInternal medicineAdverse effectPopulationOncologyCancerResponse Evaluation Criteria in Solid TumorsPhases of clinical researchPaclitaxelClinical trialSurgeryEnvironmental healthPancreatic and Hepatic Oncology ResearchPancreatitis Pathology and TreatmentRenal cell carcinoma treatment